Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Brain : a Journal of Neurology
|
March 19, 2011
Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development
Emanuele Zurolo, Anand Iyer, Mattia Maroso, et al.
Molecular Biosystems
|
June 23, 2010
Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance in vitro and in vivo
Maria B Laursen, Malgorzata M Pakula, Shan Gao, et al.
Frontiers in Cellular Neuroscience
|
August 24, 2023
Corrigendum: Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody
Florine Seidel, Kees Fluiter, Robert Kleemann, et al.
Plos One
|
October 24, 2017
Inhibition of miR-142-5P ameliorates disease in mouse models of experimental colitis
Nicolette W Duijvis, Perry D Moerland, Cindy Kunne, et al.
Journal of Lipid Research
|
March 13, 2026
Longitudinal analysis of lipid changes in the sciatic nerve caused by overexpression of PMP22 in murine models of CMT1A
Tom P Hellings, Naima Lamzira-Arichi, Jeroen P Vreijling, et al.
Journal of Neurotrauma
|
August 14, 2013
Traumatic brain injury in rats induces lung injury and systemic immune suppression
Jan-Dirk Vermeij, Hamid Aslami, Kees Fluiter, et al.
Human Molecular Genetics
|
October 21, 2011
A frameshift mutation in LRSAM1 is responsible for a dominant hereditary polyneuropathy
Marian A J Weterman, Vincenzo Sorrentino, Paul R Kasher, et al.
The American Journal of Pathology
|
October 26, 2010
Silencing the expression of Ras family GTPase homologues decreases inflammation and joint destruction in experimental arthritis
Daphne de Launay, Jeroen Vreijling, Linda M Hartkamp, et al.
Trials
|
December 5, 2021
Safety and efficacy of C1-inhibitor in traumatic brain injury (CIAO@TBI): study protocol for a randomized, placebo-controlled, multi-center trial
Inge A M van Erp, Thomas A van Essen, Kees Fluiter, et al.
International Journal of Molecular Sciences
|
September 23, 2022
Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice
Florine Seidel, Robert Kleemann, Wim van Duyvenvoorde, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Brain : a Journal of Neurology
|
March 19, 2011
Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development
Emanuele Zurolo, Anand Iyer, Mattia Maroso, et al.
Molecular Biosystems
|
June 23, 2010
Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance in vitro and in vivo
Maria B Laursen, Malgorzata M Pakula, Shan Gao, et al.
Frontiers in Cellular Neuroscience
|
August 24, 2023
Corrigendum: Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody
Florine Seidel, Kees Fluiter, Robert Kleemann, et al.
Plos One
|
October 24, 2017
Inhibition of miR-142-5P ameliorates disease in mouse models of experimental colitis
Nicolette W Duijvis, Perry D Moerland, Cindy Kunne, et al.
Journal of Lipid Research
|
March 13, 2026
Longitudinal analysis of lipid changes in the sciatic nerve caused by overexpression of PMP22 in murine models of CMT1A
Tom P Hellings, Naima Lamzira-Arichi, Jeroen P Vreijling, et al.
Journal of Neurotrauma
|
August 14, 2013
Traumatic brain injury in rats induces lung injury and systemic immune suppression
Jan-Dirk Vermeij, Hamid Aslami, Kees Fluiter, et al.
Human Molecular Genetics
|
October 21, 2011
A frameshift mutation in LRSAM1 is responsible for a dominant hereditary polyneuropathy
Marian A J Weterman, Vincenzo Sorrentino, Paul R Kasher, et al.
The American Journal of Pathology
|
October 26, 2010
Silencing the expression of Ras family GTPase homologues decreases inflammation and joint destruction in experimental arthritis
Daphne de Launay, Jeroen Vreijling, Linda M Hartkamp, et al.
Trials
|
December 5, 2021
Safety and efficacy of C1-inhibitor in traumatic brain injury (CIAO@TBI): study protocol for a randomized, placebo-controlled, multi-center trial
Inge A M van Erp, Thomas A van Essen, Kees Fluiter, et al.
International Journal of Molecular Sciences
|
September 23, 2022
Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice
Florine Seidel, Robert Kleemann, Wim van Duyvenvoorde, et al.
Page
of 4